| Ytd | -17.45% | |
| 1y | -20.65% |
| Open | 1.26 | Prev Close | 1.28 | Low | 1.17 | High | 1.29 | Mkt Cap | 156.53M |
| Vol | 144.47K | Avg Vol | 206.70K | EPS | -0.16 | P/E | N/A | Forward P/E | -13.63 |
| Beta | 0.18 | Short Ratio | 0.57 | Inst. Own | 1.76% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-08 | 50-d Avg | 1.31 | 200-d Avg | 1.53 | 1yr Est | 3.00 |
Qualcomm Inc (NASDAQ:QCOM, XETRA:QCI) outlined higher long-term revenue and earnings targets at its
Tiziana Life Sciences Ltd (NASDAQ:TLSA) said the last patient in its Phase 2a clinical trial has rec
Top line data readout expected in late Q3/early Q4 INFORM-MS trial is a randomized, double-blind, pl
Top line data readout expected in late Q3/early Q4 INFORM-MS trial is a randomized, double-blind, pl
Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) ("Tiziana" or the "Company"), a biotechno